Busulfan Supplier-Buyer Network — Trade Flow Analysis

Name: Busulfan Supplier-Buyer Trade Network Dataset — 33+ Indian Exporters, 21+ Importers, 44+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Busulfan supplier network, Busulfan buyers, pharmaceutical export India, Busulfan trade data

TransData Nexus

Busulfan

India Pharmaceutical Trade Intelligence

$4.9M33 Suppliers44 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM25.9%India → PERU15.4%

ImportsUNITED STATES → India$25.5K BRAZIL → India$3.3K

#1 Supplier: INTAS PHARMACEUTICALS

Who Supplies Busulfan? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the first-largest Busulfan exporter from India, with a market share of 21.4% and a total export value of $1.1M across 109 shipments. Their average shipment value of $9.7K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TILLOMED LABORATORIES LIMITED — $404.7K across 42 shipments (38.4% of this supplier's total exports)

• TILLOMED LABORATORIES LIMITED — $302.2K across 31 shipments (28.6% of this supplier's total exports)

• TILLOMED MALTA LTD — $235.8K across 24 shipments (22.3% of this supplier's total exports)

• TILLOMED MALTA LIMITED — $61.8K across 6 shipments (5.9% of this supplier's total exports)

• TILLOMED LABORATORIES LIMITED — $50.6K across 5 shipments (4.8% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (109 shipments) at a per-shipment value of $9.7K, indicating a broad distribution network with many smaller, regular orders.

2INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the second-largest Busulfan exporter from India, with a market share of 11.5% and a total export value of $565.2K across 92 shipments. Their average shipment value of $6.1K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MYLAN INSTITUTIONAL INC GSO — $156.5K across 25 shipments (27.7% of this supplier's total exports)

• ACCORD FARMACEUTICA LTDA — $155.2K across 25 shipments (27.5% of this supplier's total exports)

• TO THE ORDER — $93.4K across 15 shipments (16.5% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES,LL — $80.4K across 13 shipments (14.2% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES,LL — $79.7K across 13 shipments (14.1% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (92 shipments) at a per-shipment value of $6.1K, indicating a broad distribution network with many smaller, regular orders.

3FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the third-largest Busulfan exporter from India, with a market share of 9.9% and a total export value of $488.1K across 77 shipments. Their average shipment value of $6.3K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 65.2% of this supplier's tracked business. Top customers include:

• FRESENIUS KABI DEUTSCHLAND GMBH — $318.3K across 50 shipments (65.2% of this supplier's total exports)

• RINQUE PHARMA S A — $54.1K across 9 shipments (11.1% of this supplier's total exports)

• FRESENIUS KABI SOUTH — $52.4K across 8 shipments (10.7% of this supplier's total exports)

• FRESENIUS KABI DEUTSCHLAND GMBH — $36.8K across 6 shipments (7.5% of this supplier's total exports)

• THE EGYPTIAN PHARMAC — $26.5K across 4 shipments (5.4% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (77 shipments) at a per-shipment value of $6.3K, indicating a broad distribution network with many smaller, regular orders.

4INTAS PHARMACEUTICALS LTD

INTAS PHARMACEUTICALS LTD is the fourth-largest Busulfan exporter from India, with a market share of 6.6% and a total export value of $324.7K across 16 shipments. Their average shipment value of $20.3K is above the market average of $13.4K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LTD serves 5 named buyers in our database. ACCORD HEALTHCARE POLSKA SP Z O O is the dominant customer, accounting for 77.1% of this supplier's tracked business. Top customers include:

• ACCORD HEALTHCARE POLSKA SP Z O O — $250.3K across 12 shipments (77.1% of this supplier's total exports)

• ACCORD HEALTHCARE S — $30.2K across 1 shipments (9.3% of this supplier's total exports)

• ACCORD UK — $28.1K across 1 shipments (8.7% of this supplier's total exports)

• BROCACEF NL HUB BROC — $14.1K across 1 shipments (4.3% of this supplier's total exports)

• PHARMADOX HEALTHCARE — $2.0K across 0 shipments (0.6% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LTD's per-shipment value of $20.3K is 52% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.

5SHILPA MEDICARE LIMITED

SHILPA MEDICARE LIMITED is the fifth-largest Busulfan exporter from India, with a market share of 3.1% and a total export value of $150.5K across 5 shipments. Their average shipment value of $30.1K is above the market average of $13.4K, suggesting premium or bulk contract pricing.

SHILPA MEDICARE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXPHAXXA SXX S — $61.0K across 2 shipments (40.6% of this supplier's total exports)

• XX HUXXN BXXSCIXXCE — $45.9K across 2 shipments (30.5% of this supplier's total exports)

• XX HEXXTHCXXE PXX LX — $32.5K across 1 shipments (21.6% of this supplier's total exports)

• XXIMEXXSDNXXHD — $11.1K across 0 shipments (7.4% of this supplier's total exports)

• XXHC XXC — $10 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: SHILPA MEDICARE LIMITED's per-shipment value of $30.1K is 125% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.

6SP ACCURE LABS PRIVATE LIMITED

SP ACCURE LABS PRIVATE LIMITED is the fifth-largest Busulfan exporter from India, with a market share of 1.4% and a total export value of $67.2K across 4 shipments. Their average shipment value of $16.8K is above the market average of $13.4K, suggesting premium or bulk contract pricing.

SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. CJSC PHARMGUIDE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• CJSC PHARMGUIDE — $67.2K across 4 shipments (100.0% of this supplier's total exports)

Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $16.8K is 26% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.

1United Kingdom

United Kingdom ranks as the first-largest destination for Busulfan imports from India, with a total trade value of $1.3M across 54 shipments — representing a 25.9% share of all Busulfan exports. The average shipment value of $23.7K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Busulfan importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 48.5% ($619.7K) of this market's total imports.

• TILLOMED LABORATORIES LTD — $619.7K (48.5% of United Kingdom's total)

• TILLOMED LABORATORIES LIMITED — $404.7K (31.7% of United Kingdom's total)

• ACCORD UK — $111.6K (8.7% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $23.7K (77% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Busulfan imports from India.

Primary Market

Secondary Market

2Peru

Peru ranks as the second-largest destination for Busulfan imports from India, with a total trade value of $756.7K across 2 shipments — representing a 15.4% share of all Busulfan exports. The average shipment value of $378.3K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Busulfan importers in Peru: ACCORD HEALTHCARE S.A.C. is the largest buyer, accounting for 94.7% ($716.8K) of this market's total imports.

• ACCORD HEALTHCARE S.A.C. — $716.8K (94.7% of Peru's total)

Key Insight: Peru's per-shipment average of $378.3K (2733% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Peru is a key market for Busulfan imports from India.

Primary Market

Secondary Market

3United States

United States ranks as the third-largest destination for Busulfan imports from India, with a total trade value of $548.0K across 10 shipments — representing a 11.1% share of all Busulfan exports. The average shipment value of $54.8K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Busulfan importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 32.8% ($179.8K) of this market's total imports.

• EVERSANA LIFE SCIENCES SERVICES,LLC — $179.8K (32.8% of United States's total)

• MYLAN INSTITUTIONAL INC GSO — $156.5K (28.6% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES,LL — $80.4K (14.7% of United States's total)

Key Insight: United States's per-shipment average of $54.8K (310% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Busulfan imports from India.

Primary Market

Secondary Market

4Germany

Germany ranks as the fourth-largest destination for Busulfan imports from India, with a total trade value of $463.2K across 60 shipments — representing a 9.4% share of all Busulfan exports. The average shipment value of $7.7K is below the global average of $13.4K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Busulfan importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 92.1% ($426.4K) of this market's total imports.

• FRESENIUS KABI DEUTSCHLAND GMBH — $426.4K (92.1% of Germany's total)

Key Insight: Germany receives frequent, smaller shipments of Busulfan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Germany is a key market for Busulfan imports from India.

Primary Market

Secondary Market

5Malta

Malta ranks as the fifth-largest destination for Busulfan imports from India, with a total trade value of $341.9K across 22 shipments — representing a 6.9% share of all Busulfan exports. The average shipment value of $15.5K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Busulfan importers in Malta: TILLOMED MALTA LTD is the largest buyer, accounting for 69.0% ($235.8K) of this market's total imports.

• TILLOMED MALTA LTD — $235.8K (69.0% of Malta's total)

• TILLOMED MALTA LIMITED — $61.8K (18.1% of Malta's total)

Key Insight: Malta's per-shipment average of $15.5K (16% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Malta is a key market for Busulfan imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Busulfan.
2.Flow Mapping: 33 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 369 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 44 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

369 Verified Shipments

33 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Busulfan

Busulfan

Who Supplies Busulfan? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Busulfan? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Busulfan Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1EMCURE PHARMACEUTICALS LIMITED

2INTAS PHARMACEUTICALS LIMITED

3FRESENIUS KABI ONCOLOGY LIMITED

4INTAS PHARMACEUTICALS LTD

5SHILPA MEDICARE LIMITED

6SP ACCURE LABS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Busulfan Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Busulfan Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

2Peru

3United States

4Germany

5Malta

People Also Ask — Busulfan Supplier & Trade Network

Busulfan Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology